GB2553736A — Method for identification of a deficient BRCA1 function
Assigned to Nadathur Estates Pvt Ltd · Expires 2018-03-14 · 8y expired
What this patent protects
The present invention is related to an in vitro method for identifying deficient BRCA1 function in a test biological sample obtained from a human individual, said method comprising the steps of: - Assaying the test sample to determine an expression profile of at least BRCA1 gene …
USPTO Abstract
The present invention is related to an in vitro method for identifying deficient BRCA1 function in a test biological sample obtained from a human individual, said method comprising the steps of: - Assaying the test sample to determine an expression profile of at least BRCA1 gene and ID4 gene; and - Establishing the ratio of BRCA1 to ID4 gene expression; Wherein a BRCA1/ID4 ratio lower than a threshold value is used as positive criterion for identification of the deficient BRCA1 function in the tested sample.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.